SEGMENT INFORMATION

6 Months Ended

Mar. 29, 2013

SEGMENT INFORMATION

17. SEGMENT INFORMATION

The Company’s operations are grouped into two reportable operating segments: Oncology Systems and X-ray Products. These reportable operating segments were determined based on how the Company’s Chief Executive Officer, its Chief Operating Decision Maker (“CODM”), views and evaluates the Company’s operations. The Company’s Ginzton Technology Center, Security and Inspection Products business and Varian Particle Therapy business are reflected in the “Other” category because these operating segments do not meet the criteria of a reportable operating segment. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on operating earnings.

The following table summarizes selected operating results information for each business segment:

	Three Months Ended						Six Months Ended
(In millions)	March 29, 2013			March 30, 2012			March 29, 2013			March 30, 2012
Revenues
Oncology Systems	$	582		$	566		$	1,106		$	1,053
X-ray Products		140			123			273			236
Total reportable segments	$	722		$	689		$	1,379		$	1,289
Other		47			32			68			57
Total company	$	769		$	721		$	1,447		$	1,346
Operating Earnings (Loss)
Oncology Systems	$	132		$	125		$	252		$	237
X-ray Products		38			33			72			60
Total reportable segments	$	170		$	158		$	324		$	297
Other		(7	)		(9	)		(18	)		(19	)
Corporate		(7	)		(5	)		(13	)		(5	)
Total company	$	156		$	144		$	293		$	273